Safety Analysis of Apatinib Combined with Chemotherapy in the Treatment of Advanced Gastric Carcinoma: A Randomised Controlled Trial

Table 5

Comparison of the incidence of adverse reactions (n (%)).

Group	n	Alimentary tract hemorrhage	Myelosuppression	Liver function damage	Skin and mucosal reaction	Thrombocytopenia	Total incidence
SG	37	2 (5.41%)	1 (2.70%)	1 (2.70%)	0 (0.00%)	2 (5.41%)	16.22% (6/37)
RG	37	3 (8.11%)	4 (10.81%)	2 (5.41%)	3 (8.11%)	4 (10.81%)	43.24% (16/37)
t							6.469
							0.011